<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03944694</url>
  </required_header>
  <id_info>
    <org_study_id>0012/84/03/19</org_study_id>
    <nct_id>NCT03944694</nct_id>
  </id_info>
  <brief_title>White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke.</brief_title>
  <acronym>DELIAS</acronym>
  <official_title>White Cell Ratios as Markers of Delirium and Outcome in Acute Ischemic Stroke. DELirium in Acute Ischemic Stroke [DELIAS]</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pomeranian Medical University Szczecin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pomeranian Medical University Szczecin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and
      other derived white cell markers as early markers of delirium and outcome after acute
      ischemic stroke (AIS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Delirium is an acute brain disorder, potentially reversible, commonly occurring in patients
      with acute ischemic stroke. The pathomechanism of delirium is related to neuroinflammatory
      process and oxidative stress. Search for readily available diagnostic marker that will aid
      clinicians in early identification of delirium is an on-going process. The aim of this study
      was to investigate the role of Neutrophil-to-Lymphocyte Ratio (NLR) and other derived white
      cell markers as early markers of delirium and outcome after acute ischemic stroke (AIS).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 30, 2015</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">March 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Early-onset-delirium.</measure>
    <time_frame>24 hours</time_frame>
    <description>Delirium within 24 hours from admission.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality at 30 days.</measure>
    <time_frame>30 days</time_frame>
    <description>Mortality determined at follow-up on day 30 after acute ischemic stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality at 1 year.</measure>
    <time_frame>1 year</time_frame>
    <description>Mortality determined at follow-up at 1 year after acute ischemic stroke.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1001</enrollment>
  <condition>Delirium</condition>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>Delirious</arm_group_label>
    <description>Patients were delirious if CAM-ICU was positive within 24 hours from admission due to acute ischemic stroke.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-delirious</arm_group_label>
    <description>Patients were delirious if CAM-ICU was negative within 24 hours from admission due to acute ischemic stroke.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Delirium assessment.</intervention_name>
    <description>Full blood count analysis.</description>
    <arm_group_label>Delirious</arm_group_label>
    <arm_group_label>Non-delirious</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive adult patients (age &gt;18 years) with acute ischemic stroke, admitted to a
        neurology department of a busy district general hospital in Poland between 30.06.2015 and
        31.03.2018. Patients with AIS were admitted to the neurology department within 48 hours of
        symptom development.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt;18 years)

          -  acute ischemic stroke

        Exclusion Criteria:

          -  hematology disorders

          -  incomplete laboratory testing

          -  no data regarding follow-up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iwona Rotter, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pomeranian Medical University Szczecin</affiliation>
  </overall_official>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 8, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 9, 2019</study_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pomeranian Medical University Szczecin</investigator_affiliation>
    <investigator_full_name>Katarzyna Kotfis</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>stroke</keyword>
  <keyword>neutrophil-to-lymphocyte ratio</keyword>
  <keyword>NLR</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

